Tarhini A - Search Results

1

Real-world outcomes of different lines and sequences of treatment in BRAF-positive advanced melanoma patients.

Betof Warner A, Tarhini A, Kang B, Nakasato A, Ling YL, Shah R, Tang J, Patel J. Betof Warner A, et al. Among authors: tarhini a. Melanoma Res. 2023 Feb 1;33(1):38-49. doi: 10.1097/CMR.0000000000000856. Epub 2022 Oct 15. Melanoma Res. 2023. PMID: 36545921

2

A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: A trial of the ECOG-ACRIN Cancer Research Group (E2607).

Kalinsky K, Lee S, Rubin KM, Lawrence DP, Iafrarte AJ, Borger DR, Margolin KA, Leitao MM Jr, Tarhini AA, Koon HB, Pecora AL, Jaslowski AJ, Cohen GI, Kuzel TM, Lao CD, Kirkwood JM. Kalinsky K, et al. Among authors: tarhini aa. Cancer. 2017 Jul 15;123(14):2688-2697. doi: 10.1002/cncr.30663. Epub 2017 Mar 23. Cancer. 2017. PMID: 28334439 Free PMC article. Clinical Trial.

3

Safety and efficacy of the antiganglioside GD3 antibody ecromeximab (KW2871) combined with high-dose interferon-α2b in patients with metastatic melanoma.

Tarhini AA, Moschos SJ, Lin Y, Lin HM, Sander C, Yin Y, Venhaus R, Gajewski TF, Kirkwood JM. Tarhini AA, et al. Melanoma Res. 2017 Aug;27(4):342-350. doi: 10.1097/CMR.0000000000000353. Melanoma Res. 2017. PMID: 28489678 Clinical Trial.

4

A unique gene expression signature is significantly differentially expressed in tumor-positive or tumor-negative sentinel lymph nodes in patients with melanoma.

Tarhini AA, Floros T, Lin HM, Lin Y, Rahman Z, Ashraf M, Vallabhaneni P, Sander C, Rao UNM, Panelli M, LaFramboise WA, Kirkwood JM. Tarhini AA, et al. Melanoma Res. 2017 Oct;27(5):429-438. doi: 10.1097/CMR.0000000000000383. Melanoma Res. 2017. PMID: 28825947 Free PMC article.

5

Sequential treatment approaches in the management of BRAF wild-type advanced melanoma: a cost-effectiveness analysis.

Tarhini A, Benedict A, McDermott D, Rao S, Ambavane A, Gupte-Singh K, Sabater J, Ritchings C, Aponte-Ribero V, Regan MM, Atkins M. Tarhini A, et al. Immunotherapy. 2018 Oct;10(14):1241-1252. doi: 10.2217/imt-2018-0085. Epub 2018 Sep 3. Immunotherapy. 2018. PMID: 30175642 Free article.

6

Postsurgical treatment landscape and economic burden of locoregional and distant recurrence in patients with operable nonmetastatic melanoma.

Tarhini A, Ghate SR, Ionescu-Ittu R, Manceur AM, Ndife B, Jacques P, Laliberté F, Nakasato A, Burne R, Duh MS. Tarhini A, et al. Melanoma Res. 2018 Dec;28(6):618-628. doi: 10.1097/CMR.0000000000000507. Melanoma Res. 2018. PMID: 30216199 Free PMC article.

7

Stage III melanoma incidence and impact of transitioning to the 8th AJCC staging system: a US population-based study.

Tarhini A, Ghate S, Ionescu-Ittu R, Shi S, Nakasato A, Ndife B, Laliberté F, Burne R, Duh MS. Tarhini A, et al. Future Oncol. 2019 Feb;15(4):359-370. doi: 10.2217/fon-2018-0671. Epub 2018 Oct 15. Future Oncol. 2019. PMID: 30317881

8

Clinical and economic outcomes associated with treatment sequences in patients with BRAF-mutant advanced melanoma.

Tarhini A, McDermott D, Ambavane A, Gupte-Singh K, Aponte-Ribero V, Ritchings C, Benedict A, Rao S, Regan MM, Atkins M. Tarhini A, et al. Immunotherapy. 2019 Mar;11(4):283-295. doi: 10.2217/imt-2018-0168. Epub 2018 Dec 19. Immunotherapy. 2019. PMID: 30563395 Free article.

9

Treatment patterns and outcomes for patients with unresectable stage III and metastatic melanoma in the USA.

Tarhini A, Atzinger C, Gupte-Singh K, Johnson C, Macahilig C, Rao S. Tarhini A, et al. J Comp Eff Res. 2019 May;8(7):461-473. doi: 10.2217/cer-2019-0003. Epub 2019 Mar 5. J Comp Eff Res. 2019. PMID: 30832505 Free article.

10

Association of BRAF V600E/K Mutation Status and Prior BRAF/MEK Inhibition With Pembrolizumab Outcomes in Advanced Melanoma: Pooled Analysis of 3 Clinical Trials.

Puzanov I, Ribas A, Robert C, Schachter J, Nyakas M, Daud A, Arance A, Carlino MS, O'Day SJ, Long GV, Margolin KA, Dummer R, Schadendorf D, Lutzky J, Ascierto PA, Tarhini A, Lin J, Mogg R, Homet Moreno B, Ibrahim N, Hamid O. Puzanov I, et al. Among authors: tarhini a. JAMA Oncol. 2020 Aug 1;6(8):1256-1264. doi: 10.1001/jamaoncol.2020.2288. JAMA Oncol. 2020. PMID: 32672795 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

215 results

Search Page